Literature DB >> 7619325

Increased extracellular dopamine in the nucleus accumbens and striatum of the female rat during paced copulatory behavior.

P G Mermelstein1, J B Becker.   

Abstract

Five groups of ovariectomized rats were tested during in vivo microdialysis, and concentrations of dopamine (DA) and its metabolites were determined in dialysate. In striatum, DA increased more in hormone-primed ovariectomized female rats pacing copulation than in those engaging in sex that could not pace, those that were hormone primed but tested without a male present, or oil-treated groups (p < .02). Administration of estrogen before microdialysis resulted in enhanced striatal DA in response to a male rat relative to the animals tested without a male (p < .06). Female rats that were pacing sexual behavior also exhibited a greater increase in accumbens DA than did the no-male, estrogen-primed, or oil-treated groups (p < .015). Nonpacing animals displayed a significant decrease in DA from accumbens 30 min after introduction of the male rat (p < .05) but otherwise were not different from pacing animals. Estrogen-treated animals also had an enhanced increase in accumbens DA compared with oil-treated rats (p < .05). These data suggest that DA release in the striatum and accumbens is dependent on the context in which sexual behavior occurs and that estrogen may in part modulate these dopaminergic responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619325     DOI: 10.1037//0735-7044.109.2.354

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  42 in total

1.  The testosterone metabolite 3α-diol enhances female rat sexual motivation when infused in the nucleus accumbens shell.

Authors:  Eliana L Sánchez Montoya; Lizaida Hernández; Jennifer L Barreto-Estrada; José G Ortiz; Juan Carlos Jorge
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

Review 2.  Temporal and concentration-dependent effects of oestradiol on neural pathways mediating sexual receptivity.

Authors:  P Micevych; K Sinchak
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 3.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

4.  Repeated quinpirole treatments produce neurochemical sensitization and associated behavioral changes in female hamsters.

Authors:  Julia A Chester; Amanda J Mullins; Chau H Nguyen; Val J Watts; Robert L Meisel
Journal:  Psychopharmacology (Berl)       Date:  2006-07-19       Impact factor: 4.530

Review 5.  Sexual experience in female rodents: cellular mechanisms and functional consequences.

Authors:  Robert L Meisel; Amanda J Mullins
Journal:  Brain Res       Date:  2006-09-15       Impact factor: 3.252

Review 6.  Neural progestin receptors and female sexual behavior.

Authors:  Shaila K Mani; Jeffrey D Blaustein
Journal:  Neuroendocrinology       Date:  2012-09-14       Impact factor: 4.914

7.  Interactions among ovarian hormones and time of testing on behavioral sensitization and cocaine self-administration.

Authors:  Hongyan Yang; Wei Zhao; Ming Hu; Jill B Becker
Journal:  Behav Brain Res       Date:  2007-07-12       Impact factor: 3.332

8.  ERαΔ4, an ERα splice variant missing exon4, interacts with caveolin-3 and mGluR2/3.

Authors:  Angela M Wong; Alexandra K Scott; Caroline S Johnson; Margaret A Mohr; Melinda Mittelman-Smith; Paul E Micevych
Journal:  J Neuroendocrinol       Date:  2019-05-23       Impact factor: 3.627

9.  6-hydroxydopamine lesions enhance progesterone-facilitated lordosis of rats and hamsters, independent of effects on motor behavior.

Authors:  Cheryl A Frye; Sandra M Petralia; Madeline E Rhodes; Joseph F DeBold
Journal:  Physiol Behav       Date:  2009-09-22

Review 10.  Sexual differentiation of motivation: a novel mechanism?

Authors:  Jill B Becker
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.